Press & media

MYoroface, the Swedish healthtech company behind the IQoro, has been named one of the fastest growing companies in Europe. The award comes from the annual FT 1000 report developed by The Financial Times, which ranks European companies that have achieved the highest growth in recent years. In the UK, around 13 million people suffer from […]

Swedish scale-up company challenges traditional ways of treating reflux

Reflux-based diseases are a global problem, affecting not only individuals’ quality of life, but also causing severe socio-economic consequences. Reflux is chronic, and in the western world, as many as 20 percent of the population are suffering from reflux-based symptoms that can be treated with IQoro – a neuromuscular training device.

IQoro on prescription

IQoro is available on prescription on the NHS from 1st May 2022. This means your GP can prescribe IQoro as a treatment, if they find it to be a suitable treatment for you. How to get IQoro on prescription IQoro is still a new device to many health professionals. Some might have heard of it briefly […]

Read all press releases